CADENCE PHARMACEUTICALS ANNOUNCES $25 MILLION FINANCING

Cadence Pharmaceuticals, Inc., a hospital-focused specialty pharmaceutical company, today announced the completion of a $25 million Series A preferred stock financing. Domain Associates led the round which included ProQuest Investments, BB Biotech

Ventures, CDIB BioScience Venture Management, Windamere Venture Partners, and private investors.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/10-11-2005/0004165321&EDATE=)